Leigh Zawel

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leigh Zawel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. Chief Scientific Officer, Small Molecules Common Stock 69,785 $869,521 $12.46 11 Feb 2022 Direct
Cullinan Oncology, Inc. Chief Scientific Officer, Small Molecules Stock Option (Right to Buy) 65,000 11 Feb 2022 Direct

Insider Reports Filed by Leigh Zawel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Oncology, Inc. 11 Feb 2022 2 $0 4 Chief Scientific Officer, Small Molecules 15 Feb 2022, 15:47
CGEM Cullinan Oncology, Inc. 15 Oct 2021 1 -$489,350 4 Chief Scientific Officer, Small Molecules 18 Oct 2021, 16:15
CGEM Cullinan Oncology, Inc. 07 Oct 2021 1 -$26,975 4 Chief Scientific Officer, Small Molecules 12 Oct 2021, 16:30
CGEM Cullinan Oncology, Inc. 20 Sep 2021 1 -$187,894 4 Chief Scientific Officer, Small Molecules 21 Sep 2021, 16:30
CGEM Cullinan Oncology, Inc. 07 Sep 2021 1 -$814,016 4 Chief Scientific Officer, Small Molecules 08 Sep 2021, 16:15
CGEM Cullinan Oncology, Inc. 23 Aug 2021 1 -$815,422 4/A Officer 26 Aug 2021, 19:14
CGEM Cullinan Oncology, Inc. 09 Aug 2021 5 -$752,850 4/A Officer 26 Aug 2021, 19:20